Postpartum Care / Hospital Operations7 min read

Gestational Diabetes Postpartum Follow-Up Program for Saudi Hospitals: Closing the Glucose-Test Gap After Delivery

By

A gestational diabetes postpartum follow-up program is a hospital routine that orders, books and tracks a glucose test for every woman with gestational diabetes after delivery, then recalls her for repeat testing. At one Jeddah tertiary centre, screening was ordered for 72.5% of 642 women with gestational diabetes but completed by only 20.2%.

Key takeaways

  • A retrospective cohort at King Abdulaziz Medical City in Jeddah (2016 to 2018) found that postpartum diabetes screening was ordered for 466 of 642 women with gestational diabetes (72.5%) but completed by 130 (20.2%).
  • At King Khalid University Hospital in Riyadh, among 133 women with gestational diabetes tested one year after delivery, 44% were normoglycaemic, 45% had impaired glucose tolerance and 11% had diabetes.
  • The American Diabetes Association recommends a 75-g oral glucose tolerance test at 4 to 12 weeks postpartum and repeat screening every 1 to 3 years if the result is normal.
  • The gap sits between the order and the result. A program closes it with a named owner, a booked date before discharge, a recall for missed tests and a list that shows who is still untested.
Illustrative postpartum glucose-test pathway connecting a laboratory result, recall calendar and hospital
On this page

What the Saudi data show

Gestational diabetes does not end the clinical story at delivery. The Jeddah cohort described 642 women with gestational diabetes who delivered at one tertiary centre between 2016 and 2018. Most were at high risk: 87.7% were overweight or obese, 42.7% had four or more previous deliveries and 33.3% had a family history of diabetes. Screening was ordered for 72.5%, yet only 20.2% were screened. Delivery mode was associated with screening (p=0.042), and women who had a cesarean section were screened more often than those who delivered vaginally. The authors describe a substantial screening gap alongside a high incidence of postpartum diabetes among those tested.

A second Riyadh study followed women one year after delivery. Of 133 participants (from 316 eligible women, so participation was partial), 58 were normoglycaemic, 60 had impaired glucose tolerance and 15 had diabetes. That is a single-centre sample, but it explains why the test matters: for many women, the result changes what happens next.

A third study from King Abdulaziz University Hospital looked at what predicted a test at six weeks. Frequent postpartum hospital follow-up visits, gestational weight gain, being told about the risks of high blood glucose and having a plan for postpartum screening were all associated with testing. Each of those is something a hospital can influence.

Why an order is not a test

In many hospitals the order is written. The patient is told to return. The result is not tracked, because the order sits in one department and the lab, the postnatal clinic and the diabetes clinic each see only their part. After delivery the woman is focused on the baby, travel can be long, and the six-week visit may be with a different team. The order has been given; the test has not happened; nobody sees the difference.

What the program contains

Clinical decisions belong to the obstetrician and endocrinologist. The program makes sure those decisions are carried out. A workable version has seven parts:

  1. A flag at diagnosis. Every woman diagnosed with gestational diabetes is entered in a registry at that point, not at discharge.
  2. A booked date before discharge. The postpartum test is scheduled while the woman is still in hospital, with the date in her record and in her hand. The ADA window is 4 to 12 weeks after delivery; the clinician sets the exact date.
  3. A named owner. One role, for example a diabetes educator or postnatal coordinator, is responsible for the list. Without a name, the list is nobody's job.
  4. Clear test instructions. Preparation and timing are explained in Arabic, in writing, to the woman and a family member.
  5. Reminders and recall. A reminder before the date, and a recall within days if the test is not done. Reminders go only to patients who agreed to receive them.
  6. Result tracking. The result is recorded in the same list. A normal result sets the next screening date, in line with the ADA recommendation of repeat testing every 1 to 3 years. An abnormal result is routed to the clinician the same day.
  7. A hand-off. The primary care team or family physician receives a short summary, because later screening usually happens there.

Who does what

  • Obstetrics: diagnoses gestational diabetes, counsels the woman, writes the order.
  • Diabetes or endocrine service: advises on abnormal results and prevention.
  • Lab: makes the test easy to book and returns results to the registry, not only to the chart.
  • Postnatal coordinator: owns the list, the reminders and the recall.
  • Primary care: receives the hand-off and continues periodic screening.
  • The woman: knows why the test matters and when it is due.

Where a digital platform helps, and where it does not

A platform can keep the registry, show the due date for each woman, produce a daily list of overdue tests, send reminders in Arabic or English, record results and notify the clinician when a result is abnormal. It does not decide the test, interpret the result or replace the visit. For the wider design of a postnatal pathway, see our article on a hybrid antenatal and postnatal follow-up platform. The same recall logic is used in a diabetic foot ulcer follow-up program, and a group that already tracks patients across branches can reuse it, as described in our guide to a chronic disease management platform for multi-branch hospitals.

What to measure

Measure what the hospital controls:

  • Share of women with gestational diabetes who have a postpartum test date booked before discharge.
  • Share who complete the test within the window the clinician set.
  • Median days from the due date to the completed test.
  • Share of missed tests recovered by recall.
  • Share of normal results with the next screening date recorded.

Clinical outcomes, such as how many women are later diagnosed with diabetes, belong to the clinical team and need careful interpretation.

Data protection

Pregnancy and diabetes records are sensitive health data. Reminders, family contacts and any sharing with primary care should follow patient consent and the hospital's own policies under Saudi Arabia's Personal Data Protection Law. Confirm consent wording, access rules and hosting with your legal and data protection team.

An illustrative scenario

This is a hypothetical example, not a real patient. A 31-year-old woman has gestational diabetes managed with diet in a hospital in Jeddah. She delivers by cesarean section. Before she goes home, the coordinator books her glucose test for the postnatal visit and sends the instructions in Arabic. Two days after the date, the system shows she has not attended. The coordinator calls, finds that she could not travel with a newborn, and rebooks at a lab near her home. The result goes into the registry, the clinician sees it the same day, and the next screening date is set. Nothing about the clinical plan changed. The only difference is that someone could see the missing test.

Start small

Pick one maternity unit and one lab. List every woman diagnosed with gestational diabetes in the last three months, find out how many have a result, and give one person the list. That baseline is more persuasive than any national figure, because it is your own.

Frequently asked questions

What is a gestational diabetes postpartum follow-up program?

It is a hospital routine that makes sure each woman with gestational diabetes has a glucose test after delivery and repeat screening afterwards. It combines a registry, a booked date, reminders, recall and result tracking.

When should the glucose test be done after gestational diabetes?

The American Diabetes Association recommends a 75-g oral glucose tolerance test at 4 to 12 weeks postpartum. Your clinician sets the date and the test for each patient.

How often should screening be repeated if the first test is normal?

The ADA recommends repeat screening every 1 to 3 years. The interval depends on the woman's risk factors and the clinician's advice.

Why do women miss the postpartum test?

In the Saudi studies cited here, testing was linked to frequent postpartum follow-up visits, to being informed about the risks of high blood glucose and to having a plan for screening. Practical barriers such as travel with a newborn also matter, so a flexible booking option helps.

Can a hospital send reminders for this test?

Yes, if patients have agreed to receive reminders and the hospital's consent and data protection rules are followed. Reminders work best when a named person acts on the overdue list.

Sources

Book a CareSync demo